White blood cell capturing device
By using a leukocyte separation unit composed of multiple columns and a deterministic lateral displacement method in the leukocyte capture device, combined with the design of the main part and the auxiliary part, the interference problem during leukocyte capture in the prior art is solved, and high efficiency and purity are achieved High white blood cell capture effect.
Patent Information
- Application Number
- CN202380029496.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-28
- Filing Date
- 2023-02-27
- Publication Date
- 2024-11-08
AI Technical Summary
Existing white blood cell capture devices tend to capture red blood cells and other coagulations when capturing white blood cells, resulting in interference when observing white blood cells, and it is difficult to avoid the captured solid floating again.
A leukocyte capture device is designed, which uses a leukocyte separation unit composed of a plane part and a plurality of columns extending along the perpendicular line of the plane part. Through the deterministic lateral displacement method (DLD method) and a specific flow path structure, the leukocytes are ensured to be Capture into the buffer and avoid capture of other particles through the main and auxiliary design.
Efficient capture of white blood cells is achieved, avoiding the capture of red blood cells and other coagulations, improving the separation purity and capture efficiency of white blood cells, and ensuring the stability of flow.
Smart Images

Figure CN118922704A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a leukocyte capturing device. Background Art
[0002] DNA is damaged by exposure to radiation and the influence of the living environment. Damaged DNA is closely related to diseases such as cancer. In the past, in order to analyze the damage of DNA, the method of centrifuging blood, taking out white blood cells, staining them, and observing them on a slide was adopted.
[0003] In addition, a microfluidic device for capturing microparticles such as leukocytes has been proposed in the past (see Patent Document 1). In Patent Document 1, a microfluidic device with a filtering function is disclosed, which uses a microfluidic device including a concave capture part to capture and separate only solids of a specified size or larger from a solid-liquid mixture. In Patent Document 1, the purpose is that a capture part accommodates one or more solids of a specified size or larger, and completely captures the solids of a specified size or larger until reaching the terminal of a separation part equipped with multiple capture parts, without considering that only one solid is captured in a capture part for the convenience of observing the captured solids such as leukocytes. In addition, in order to prevent the solids captured by the capture part from floating again and flowing out of the capture part, it is necessary to always make the solid-liquid mixture flow from the inlet to the outlet of the microfluidic device.
[0004] Prior art literature
[0005] Patent Literature
[0006] Patent Document 1: Japanese Patent Application Publication No. 2009-109232 Summary of the invention
[0007] Technical problem to be solved by the invention
[0008] However, in the conventional method, red blood cells, proteins, and the like are contained in the liquid to be captured for capturing white blood cells, and these coagulated substances may be captured together with the white blood cells, thereby interfering with the observation of the white blood cells.
[0009] The present invention aims to solve the above-mentioned technical problems. That is, the present invention aims to provide a leukocyte capturing device that can efficiently capture leukocytes and that is difficult to capture other leukocytes.
[0010] Solutions to Solve Problems
[0011] The present invention includes the following (1) to (6).
[0012] (1) A leukocyte capturing device that allows a blood-containing body to pass therethrough and captures leukocytes contained in the blood-containing body, comprising:
[0013] A sample inlet for introducing the blood-containing body X1;
[0014] Buffer inlet, for introduction of buffer Y1;
[0015] The leukocyte separation unit is configured to have a planar portion and a plurality of columns extending in a direction perpendicular to the planar portion, wherein the blood-containing body X1 and the buffer solution Y1 flow in a specific same direction on the surface of the planar portion in a manner that they are adjacent to each other and between the column and another column adjacent thereto,
[0016] When the surface of the planar portion is viewed from a direction parallel to a perpendicular line to the surface of the planar portion, the columns form a plurality of rows, each of which is arranged to form an angle θ with respect to the same direction Z in which the blood-containing fluid X1 and the buffer solution Y1 flow.
[0017] In the direction perpendicular to the same direction Z when the surface of the planar portion is observed from a direction parallel to a perpendicular line to the surface of the planar portion, in the case of a structure using a deterministic lateral displacement method (DLD method) in which the interval between the pillar and another pillar adjacent thereto is set to g, Dc=1.4g×(1 / tanθ) -0.48 The defined boundary diameter Dc is smaller than the diameter of the white blood cell,
[0018] In the process that the blood-containing body X1 and the buffer solution Y1 flow in the same specific direction Z, the white blood cells are separated from the blood-containing body X1, the white blood cells are contained in the buffer solution Y1, and the buffer solution Y2 containing the white blood cells and the blood-containing body X2 which is the remaining part from which the white blood cells are separated are generated and discharged;
[0019] a main part, which allows the buffer solution Y2 discharged from the leukocyte separation unit to pass therethrough and captures the leukocytes contained in the buffer solution Y2;
[0020] an auxiliary section through which the blood-containing body X2 discharged from the leukocyte separation unit passes and has the same flow path resistance as that of the main section; and
[0021] an outlet for the liquid to flow out after passing through the main part and the auxiliary part,
[0022] The main part is composed of:
[0023] The main part has a planar portion and a plurality of convex portions arranged on the planar portion, and the buffer Y2 entering from the inlet passes on the surface of the planar portion in the main part and between the convex portion and another convex portion adjacent to the convex portion, and is discharged from the outlet.
[0024] The convex portions are provided in layers on the surface of the planar portion, each layer includes a plurality of the convex portions, and the convex portions are configured so that the buffer Y2 that has passed through the layer on the inlet side passes through the layer on the outlet side adjacent to the layer on the inlet side.
[0025] A capture portion having a width between the convex portion and another convex portion adjacent to the convex portion and a bypass portion having a width between 2 and 7.5 μm and 8 and 20 μm is formed in each layer.
[0026] The width of the inlet side portion of the two convex portions constituting the capture portion is chamfered so as to gradually narrow toward the depth of the capture portion.
[0027] The capturing portion that is a part of another adjacent layer is arranged facing the outlet side of the bypass portion of all or part of a specific layer.
[0028] (2) The leukocyte capturing device according to (1), wherein the auxiliary part has the same structure as the main part.
[0029] (3) The leukocyte capturing device according to (1) or (2), wherein in the main portion, a specific layer and another layer adjacent to the specific layer have a width of 8 to 30 μm.
[0030] (4) The leukocyte capturing device according to any one of (1) to (3), wherein in the main portion, a ratio of a width of the bypass portion to a width of the capturing portion is greater than 1 and less than 3.
[0031] (5) A white blood cell capture device according to any one of (1) to (4), wherein, in the main portion, a portion other than the capture portion at the end face on the inlet side of the convex portion extends parallel to the layer direction, and an end face in the convex portion constituting the bypass portion extends in a direction perpendicular to the layer direction.
[0032] (6) The leukocyte capturing device according to any one of (1) to (5), wherein the boundary diameter Dc is 5 μm or more and less than 10 μm.
[0033] Effects of the Invention
[0034] According to the present invention, it is possible to provide a leukocyte capturing device that can efficiently capture leukocytes and that is difficult to capture other leukocytes. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] Figure 1 This is a schematic plan view showing the leukocyte capturing device of the present invention.
[0036] Figure 2 yes Figure 1 AA line section view (shorthand section view) in.
[0037] Figure 3 It is an enlarged view of the junction between the flow channel 5 and the flow channel 6 and the inlet 10in of the leukocyte separation unit 10.
[0038] Figure 4 yes Figure 1 Magnified view of the surface (schematic diagram).
[0039] Figure 5 This is a schematic diagram when the surface of the main portion 50 is viewed from a direction parallel to a perpendicular line of the surface of the main portion 50 .
[0040] Figure 6 yes Figure 5 Enlarged view of B in (schematic diagram).
[0041] Figure 7 yes Figure 5 CC line profile in.
[0042] Figure 8 This is a microscope photograph (eyepiece 10 times x objective lens 10 times) of the leukocyte capturing device of the present invention in the example. DETAILED DESCRIPTION
[0043] The leukocyte capturing device of the present invention will be described.
[0044] In the leukocyte capture device of the present invention, the blood-containing fluid entering from the inlet flows toward the outlet by a pump (syringe pump, etc.), hydrostatic pressure, electroosmotic flow, etc. In this process, the leukocytes are moved from the blood-containing fluid into the buffer solution, and then captured by the capture portion between the convex portion in the main portion and another convex portion adjacent thereto.
[0045] The leukocyte capturing device of the present invention can be produced, for example, by injecting rubber into a mold having a flow path pattern formed therein to obtain a flow path sheet, and then bonding the sheet to a glass substrate.
[0046] The leukocyte capturing device of the present invention will be described with reference to the drawings.
[0047] Figure 1 It is a schematic plan view showing the leukocyte capturing device 1 of the present invention.
[0048] Figure 1 The leukocyte capturing device 1 of the present invention shown in the figure is obtained by bonding a flow channel sheet obtained by injecting rubber into a mold having a flow channel pattern formed therein to a glass substrate.
[0049] However, the cover (described later) covering the upper surface of the leukocyte capturing device 1 of the present invention is not shown. Figure 1 .
[0050] The leukocyte capturing device of the present invention described below using the drawings is a preferred embodiment and is an example. The leukocyte capturing device of the present invention is not limited to the embodiment shown in the drawings.
[0051] The leukocyte capturing device 1 of the present invention includes a sample inlet 3 , a buffer inlet 4 , a leukocyte separation unit 10 , a main section 50 , an auxiliary section 70 , and an outlet 9 .
[0052] <Sample entrance>
[0053] A blood-containing body X1 is introduced into the sample inlet 3 .
[0054] The sample inlet 3 may be a hole in which the introduced blood-containing body X1 can temporarily stay.
[0055] For example, if Figure 1 In the embodiment shown, through holes are formed in a flow channel sheet obtained by injecting rubber into a mold having a flow channel pattern, and the sheet is bonded to a glass substrate, thereby forming holes in which the blood-containing body X1 can temporarily stay, and the holes can be used as the sample inlet 3 .
[0056] The sample inlet 3 and the inlet 10 in of the leukocyte separation unit 10 are connected via a flow path 5 , and the blood-containing body X1 introduced into the sample inlet 3 passes through the flow path 5 and is introduced into the leukocyte separation unit 10 from the inlet 10 in.
[0057] The flow path 5 is constituted by, for example, pillars. The pillars prevent the flow path 5 from being blocked when a through-hole is formed in a flow path sheet obtained by injecting rubber into a mold having a flow path pattern formed therein and the sheet is bonded to a glass substrate.
[0058] Here, the blood-containing body X1 is not particularly limited as long as it is a liquid containing blood of animals including humans, and may be, for example, a mixture of human blood added to phosphate buffered saline (PBS), anticoagulant, staining solution, etc. Alternatively, the blood-containing body may be the blood of animals including humans itself.
[0059] <Buffer inlet>
[0060] The buffer solution inlet 4 is used for introducing the buffer solution Y1.
[0061] The buffer inlet 4 may be a hole in which the introduced buffer Y1 can temporarily stay.
[0062] For example, if Figure 1 In the embodiment shown, through holes are formed in a flow path sheet obtained by injecting rubber into a mold having a flow path pattern, and the sheet is bonded to a glass substrate, thereby forming holes in which the buffer solution Y1 can temporarily stay, and the holes can serve as the buffer solution inlet 4 .
[0063] The buffer inlet 4 and the inlet 10 in of the leukocyte separation unit 10 are connected via a flow path 6 , and the buffer Y1 introduced into the buffer inlet 4 passes through the flow path 6 and is introduced from the inlet 10 in into the leukocyte separation unit 10 .
[0064] The flow channel 6 is constituted by, for example, pillars, similarly to the flow channel 5 .
[0065] Here, the buffer Y1 may be any reagent used for analysis of DNA damage, and may be, for example, phosphate buffered saline (PBS), paraformaldehyde (PFA), DAPI, or the like.
[0066] <Leukocyte separation unit>
[0067] Regarding the leukocyte separation unit 10, in addition to Figure 1 In addition, Figure 2 , Figure 3 and Figure 4 Provide explanation.
[0068] Figure 2 yes Figure 1 AA line section view (rough section view) in Figure 3 This is an enlarged view of the junction between the flow channel 5 and the flow channel 6 and the inlet 10in of the leukocyte separation unit 10. Figure 4 yes Figure 1 An enlarged view (schematic view) of the surface of the leukocyte separation unit 10 in FIG.
[0069] like Figure 2 As shown, the leukocyte separation unit 10 includes a planar portion 11 and a plurality of columns 13 extending in a direction perpendicular to the planar portion 11 .
[0070] As described above, in this example, the flow path sheet is formed by bonding a flow path sheet obtained by injecting rubber into a mold having a flow path pattern formed therein to a glass substrate, and the glass substrate constitutes the flat surface portion 11 .
[0071] in addition, Figure 2 The leukocyte separation unit 10 shown has a plate-like cover 15 to cover the upper portion of the column 13 (at Figure 1 , Figure 4 The description of the cover 15 is omitted). Figure 2 The boundary between the column 13 and the cover 15 is shown by a dotted line, but the column 13 and the cover 15 may be integrated or separable. By setting the shape of the mold for injecting rubber to obtain the flow path sheet to a flow path pattern in which the column 13 and the cover 15 are integrated, a flow path sheet in which the column 13 and the cover 15 are formed integrally can be obtained.
[0072] The blood-containing body X1 and the buffer solution Y1 are disposed on the surface 11 of the flat portion 11. S The liquid flows on the column 13 and between the column 13 and another column 13 adjacent thereto.
[0073] In addition, if Figure 3 As shown in FIG. 1 , the blood-containing body X1 that reaches the inlet 10in of the leukocyte separation unit 10 from the flow path 5 and flows into the leukocyte separation unit 10 from the inlet 10in and the buffer solution Y1 that reaches the inlet 10in of the leukocyte separation unit 10 from the flow path 6 and flows into the leukocyte separation unit 10 from the inlet 10in flow together in a specific direction (the same direction Z) inside the leukocyte separation unit 10. That is, the direction F in which the blood-containing body X1 flows in the leukocyte capturing device 10 is X With buffer Y1 flowing in the direction F Y Approximately parallel, this direction is set to be the same direction Z.
[0074] Furthermore, the blood-containing body X1 and the buffer solution Y1 are each substantially laminar flow. Figure 3 In order to exist in the direction shown F X The arrow shows the direction F Y The liquid flows adjacent to each other, bounded by a dotted line between the arrows and parallel to the arrows indicating the same direction Z.
[0075] This is mainly because the Reynolds numbers of the blood-containing body X1 and the buffer Y1 become very low.
[0076] Figure 4 The surface 11 of the plane portion 11 S is an enlarged view of the surface 11 S The figure shows the situation where the plane portion 11 is observed in a direction parallel to the perpendicular line. Figure 4 As shown, the columns 13 are arranged to form a plurality of rows, and the white blood cells contained in the blood-containing body X1 are separated from other red blood cells, platelets, etc. by the deterministic lateral displacement (DLD) method. The diameter of the white blood cells in the blood is about 10 to 20 μm, the diameter of the red blood cells is about 7 to 8 μm, and the diameter of the platelets is 2 to 3 μm. Since the white blood cells are the largest, they can be separated by the DLD method.
[0077] Regarding the DLD method, Naotomo Tottori and three others, "Development of Deterministic Lateral Displacement Device for Separation of Particles", 2015 Precision Engineering Society Spring Conference Academic Lecture Papers, Public Interest Institution Precision Engineering Society, 2015, p743-744, and International Publication No. 2016 / 136273. The DLD method is a technology that uses multiple columns regularly arranged in a microfluidic device to separate large particles from small particles in a liquid flow in which the particles are dispersed.
[0078] like Figure 4 As shown, the columns 13 are arranged in a plurality of rows, and each row is arranged at an angle θ with respect to the same direction Z in which the blood-containing body X1 and the buffer solution Y1 flow.
[0079] Furthermore, the white blood cells 20 move obliquely along the inclination of the column 13. In contrast, the small particles 22 with a smaller diameter than the white blood cells 20 change the direction of flow due to the column 13 and move relative to the direction of flow (F X Therefore, when the blood-containing body X1 and the buffer solution Y1 flow in the specific same direction Z on the plane portion 11 in the leukocyte capturing device 10 in such a manner that they are adjacent to each other, the leukocytes 20 in the blood-containing body X1 move toward the buffer solution Y1 side, and the leukocytes 20 move from the interface between the laminar flow of the blood-containing body X1 and the laminar flow of the buffer solution Y1 into the buffer solution Y1.
[0080] Along the flow direction of the blood-containing body X1 (F X The boundary diameter Dc between small particles advancing in the same direction (Z) and large particles advancing obliquely is calculated by the following formula 1 based on "Development of a particle separation device using a deterministic lateral displacement method" and International Publication No. 2016 / 136273.
[0081] Formula 1: Dc = 1.4 g N -0.48
[0082] Here, g is in Figure 4 The surface 11 of the flat surface portion 11 shown in FIG. S In the figure where the plane portion 11 is observed in a direction parallel to the perpendicular line, relative to the flow direction (F X The interval between the pillars 13 in the direction perpendicular to the same direction (Z), N is the number of flow streams, and is expressed by the following formula.
[0083] N=1 / ε
[0084] Here, ε is the row shift fraction, ie, the offset rate of the column 13, ε=tanθ.
[0085] The boundary diameter Dc is calculated from the following equation equivalent to equation 1 based on International Publication No. 2016 / 136273.
[0086] Dc=1.4g·ε 0.48
[0087] Particles with diameters smaller than the boundary diameter Dc generally move along the flow direction, and particles with diameters larger than the boundary diameter Dc move obliquely. As described above, the diameter of the white blood cell 20 is larger than that of the others, so by using Dc = 1.4g × (1 / tanθ) -0.48 The defined boundary diameter Dc is set smaller than the diameter of the leukocytes and larger than other particles (platelets, etc.) to be separated, so that the leukocytes 20 can move obliquely along the inclination of the column 13 and move into the buffer solution Y1 as described above.
[0088] For example, if the boundary diameter Dc is set to be greater than 5 μm and less than 10 μm, the boundary diameter Dc is smaller than the diameter of leukocytes (about 10 to 20 μm) and larger than other particles to be separated (platelets, etc.), thereby enabling efficient separation of leukocytes.
[0089] It should be noted that in Figure 4 The number and position of the columns 13 may not be exact. Figure 4 In the figure, the cross-sectional shape of the column 13 is circular, but the cross-sectional shape may be other shapes as long as the above-mentioned separation function is exerted.
[0090] Hereinafter, the buffer solution Y1 containing the white blood cells separated from the blood-containing body X1 as described above is referred to as the buffer solution Y2.
[0091] In addition, hereinafter, the remainder obtained by separating white blood cells from the blood-containing body X1 is referred to as the blood-containing body X2.
[0092] Then, they are discharged from the leukocyte separation unit 10, respectively.
[0093] The buffer solution Y2 discharged from the leukocyte separation unit 10 flows toward a main section described later.
[0094] In addition, the blood-containing body X2 discharged from the leukocyte separation unit 10 is directed toward an auxiliary unit described later.
[0095] <Main Department>
[0096] The main portion 50 is a sheet that allows the buffer solution Y2 to pass therethrough and captures the white blood cells contained in the buffer solution Y2.
[0097] use Figure 5 to Figure 7 The main part 50 is set. Figure 5 This is a schematic diagram showing the surface of the main portion 50 as viewed from a direction parallel to a perpendicular line of the main portion 50. Figure 6 yes Figure 5 The enlarged view of B in (diagrammatic diagram), Figure 7 yes Figure 5 CC line profile in.
[0098] However, a cover (described later) covering the upper surface of the main portion 50 is not shown. Figure 5 , Figure 6 .
[0099] Figure 5 The illustrated main portion 50 includes an inlet 50in for allowing the buffer solution Y2 to enter the main portion 50 and an outlet 50out for allowing the buffer solution Y2 that has passed through the main portion 50 to be discharged.
[0100] It should be noted that the structure of the main part 50 is not limited to Figure 5 to Figure 7 The illustrated structure.
[0101] like Figures 5 to 7 As shown, the main portion 50 includes a planar portion 52 and a plurality of protrusions 54 provided on the planar portion 52 .
[0102] As described above, in this example, the flow path sheet is formed by bonding a flow path sheet obtained by injecting rubber into a mold having a flow path pattern formed therein to a glass substrate, and the glass substrate constitutes the flat surface portion 52 .
[0103] in addition, Figure 5 to Figure 7 The main part 50 shown has a plate-like cover 56 to cover the upper part of the protrusion 54 (at Figure 5 , Figure 6 The description of the cover 56 is omitted). Figure 7 The boundary between the convex portion 54 and the cover 56 is shown by a dotted line, but the convex portion 54 and the cover 56 may be formed integrally or separably. By setting the shape of the mold used for injecting rubber to obtain the flow path sheet to a flow path pattern in which the convex portion 54 and the cover 56 are integrally formed, a flow path sheet in which the convex portion 54 and the cover 56 are integrally formed can be obtained.
[0104] In addition, if Figure 5 As shown, the convex portion 54 is provided in a layered manner on the flat portion 52 .
[0105] exist Figure 5In the figure, the layer closest to the inlet 50in is shown as the first layer, and the layer on the outlet side (downstream side) adjacent to the first layer is shown as the second layer. In addition, a certain layer is shown as the Pth layer, the layer on the outlet side (downstream side) adjacent to the Pth layer is shown as the P+1th layer, and the layer on the outlet side (downstream side) further adjacent is shown as the P+2th layer.
[0106] In addition, each layer includes a plurality of protrusions 54. Figure 5 In FIG. 1 , an example is shown in which each layer includes seven protrusions 54 , but the number of protrusions 54 included in each layer is not particularly limited. Furthermore, the number of layers is not particularly limited either.
[0107] The buffer solution Y2 that has entered the main part 50 from the inlet 50in flows on the surface of the plane part 52, first passes through the flow path between the convex parts 54 in the first layer, and then passes through the flow path between the convex parts 54 in the second layer. After that, it is also configured to pass through the flow path between the convex parts 54 in the Pth layer, and then pass through the flow path between the convex parts 54 in the P+1th layer.
[0108] In addition, if Figure 6 As shown, in each layer, a capture portion 61 having a width L1 between a convex portion 54 and an adjacent convex portion 54 (a width of a flow path) set to 2 to 7.5 μm and a bypass portion 63 having a width L2 set to 8 to 20 μm are formed.
[0109] exist Figure 6 In the example of FIG. 5 , at each of the P-th layer, the P+1-th layer, and the P+2-th layer, the capture portion 61 and the bypass portion 63 are alternately formed as flow paths between the plurality of convex portions 54. However, in the main portion 50, the capture portion and the bypass portion formed in each layer may be not as Figure 6 For example, a plurality of capturing portions may exist continuously in a layer.
[0110] Furthermore, the capture portion 61 is arranged on the outlet side of the bypass portion 63 in a specific layer as a part of another layer adjacent thereto. Figure 6 In the example of , the capture unit 61 in the P+1th layer is arranged on the outlet side (downstream side) of the bypass unit 63 in the Pth layer.
[0111] like Figure 6 As illustrated, the bypass portion 63 in the P-th layer and the capture portion 61 in the P+1-th layer are preferably arranged in a vertical direction relative to the layer direction. More specifically, the bypass portion 63 in the P-th layer and the capture portion 61 in the P+1-th layer are preferably arranged in such a manner that when a straight line in the vertical direction relative to the layer direction is drawn, the straight line passes through the bypass portion 63 in the P-th layer and the capture portion 61 in the P+1-th layer (that is, the straight line does not touch the convex portion 54).
[0112] exist Figure 5, Figure 6 In the example shown, the white blood cells contained in the buffer solution Y2 that flows from the inlet side (upstream side) and reaches the P-th layer cannot pass through the capture section 61 in principle, so at least a part of the white blood cells is captured by the capture section 61 of the P-th layer. If the white blood cells are captured, the capture section 61 is blocked. On the other hand, even if the buffer solution Y2 contains components other than white blood cells (red blood cells, platelets, etc.), these components are not captured by the capture section 61 of the P-th layer, and reach the P+1-th layer through the capture section 61 or the bypass section 63. In addition, all the components contained in the buffer solution Y2 that has reached the P-th layer can pass through the bypass section 63. As a result, the white blood cells that are not captured by the capture section 61 of the P-th layer pass through the bypass section 63 of the P-th layer to reach the P+1-th layer, and at least a part of the white blood cells that are not captured by the capture section 61 of the P-th layer are captured by the capture section 61 in the P+1-th layer. Here, the capturing section 61 in the P+1th layer is arranged on the outlet side (downstream side) of the bypass section 63 in the Pth layer, so the white blood cells passing through the bypass section 63 in the Pth layer are easily captured by the capturing section 61 in the P+1th layer.
[0113] exist Figure 5 , Figure 6 In the top view shown, the convex portion 54 is a rectangular shape in which a part of the corners of the four corners of the rectangle is cut off (for example, by a straight line or a curve) to be chamfered. The area of the chamfered portion cut off (for example, by a straight line or a curve) is preferably smaller than the area (projected area) of the captured leukocytes.
[0114] In addition, if Figure 6 As shown in the example, the entrance side portions of the two convex portions 54 constituting the capture portion 61 are chamfered so as to be continuously and gradually narrowed toward the depth of the capture portion 61. This is because in this case, white blood cells are easily captured by the capture portion 61. Also, once the white blood cells captured by the capture portion 61 are deformed and embedded in the chamfered portion, they are unlikely to flow out of the capture portion.
[0115] In the case of chamfering by straight line cutting, the angle formed by the chamfered straight line is preferably 30 to 60 degrees relative to the direction perpendicular to the layer direction (the direction from the inlet to the outlet). Here, in the case where the chamfer is not a straight line but is, for example, a spoon-shaped chamfer or a circular chamfer, the average value of the angle formed by its tangent line is preferably 30 to 60 degrees. If the angle is smaller than 30 degrees, there is a tendency that the speed of the flow of white blood cells to the bypass portion 63 becomes faster and the capture efficiency becomes lower. In addition, if the angle is larger than 60 degrees, there is a tendency that the probability of multiple white blood cells being captured by one capture portion 61 becomes higher.
[0116] As long as the chamfer gradually narrows toward the depth of the capture portion 61, the entry side portions of both sides of the two convex portions constituting the capture portion 61 may be chamfered or the entry side portion of one side may be chamfered. In addition, when the entry side portions of both sides are chamfered, the chamfering angles may be the same or different.
[0117] In the case where the convex portion 54 is a rectangular shape in which a part of the corners of the four corners of the rectangle are cut off and chamfered (for example, by a straight line or a curve), other leukocytes that have reached the capturing portion 61 that has captured the leukocytes move in the layer direction along the end surface of the convex portion 54, move from the bypass portion 63 to the adjacent layer on the downstream side, and are easily captured by the capturing portion 61 in the layer on the downstream side. As a result, the inventors of the present invention have found that the capturing efficiency of leukocytes is improved.
[0118] like Figure 6 As shown, in the main portion 50, the portion of the end surface of the inlet side of the convex portion 54 other than the capture portion 61 preferably extends parallel to the layer direction, and the end surface of the convex portion 54 constituting the bypass portion 63 extends in a direction perpendicular to the layer direction.
[0119] In particular, Figure 6 As shown in the case shown, if the entrance side portions of the two protrusions 54 constituting the capturing portion 61 are chamfered to continuously and gradually narrow (preferably linearly) toward the depth of the capturing portion 61, and the end face of the entrance side of the protrusion 54 extends parallel to the layer direction except for the capturing portion 61, and the bypass portion 63 extends in a direction perpendicular to the layer direction, the effect is significant, the capture efficiency of white blood cells is higher, and therefore it is preferred.
[0120] When the convex portion 54 is not rectangular in shape (eg, circular or elliptical), since its outer shape includes R, white blood cells may move along the R and not move to the capturing portion 61 in the adjacent layer on the downstream side.
[0121] The width L1 of the capturing portion 61 is 2 to 7.5 μm, preferably 3 to 6 μm, and more preferably 4 to 5 μm.
[0122] The width L2 of the bypass portion 63 is 8 to 20 μm, preferably 8.5 to 15 μm, and more preferably 9 to 10 μm.
[0123] It should be noted that the width L1 and the width L2 refer to the shortest distance between a convex portion 54 and an adjacent convex portion 54 in each layer.
[0124] The ratio (L2 / L1) of the width L2 of the bypass portion 63 to the width L1 of the capturing portion 61 is preferably greater than 1 and less than 3, and more preferably 1.5 to 2.5. This is because in this case, the flow to the bypass portion 63 is appropriately suppressed, and white blood cells are easily captured by the capturing portion.
[0125] Furthermore, the width L3 of the P-th layer and the P+1-th layer is preferably 8 to 30 μm, and more preferably 9 to 10 μm.
[0126] It should be noted that the width L3 refers to the shortest distance between the Pth layer and the P+1th layer.
[0127] Furthermore, the maximum width L4 of the chamfered portion on the entry side of the capture portion 61 is preferably 10 to 35 μm, and more preferably 15 to 25 μm.
[0128] Figure 7 The height h of the convex portion 54 shown is preferably 8 to 30 μm, and more preferably 9 to 15 μm.
[0129] <Support Department>
[0130] The auxiliary section 70 allows the blood-containing body X2 discharged from the leukocyte separation unit 10 to pass therethrough. The structure of the auxiliary section 70 is the same as that of the main section 50 described above in terms of flow channel resistance.
[0131] Here, the same flow resistance means that the difference between the pressure loss from the inlet to the outlet of the main part and the pressure loss from the inlet to the outlet of the auxiliary part is within 20% (preferably within 10%) of the higher pressure loss.
[0132] The auxiliary part 70 is preferably configured in the same manner as the main part 50. This is because the auxiliary part 70 has the same configuration as the main part 50, and thus the flow resistances to the buffer solution Y2 and the blood-containing body X2 are the same, and as a result, the flow rates of the blood-containing body X1 and the buffer solution Y1 flowing in the leukocyte separation unit 10 can be controlled to be the same, and the separation efficiency of leukocytes in the leukocyte separation unit 10 can be improved.
[0133] The leukocyte capturing device 1 of the present invention preferably has a partition wall 80 between the main portion 50 and the auxiliary portion 70 to divide them into sections.
[0134] The partition wall 80 is not particularly limited in shape or the like as long as it has the function of dividing the main portion 50 and the auxiliary portion 70 into sections.
[0135] <Export>
[0136] The liquid having passed through the main portion 50 and the auxiliary portion 70 flows out from the outlet 9 through the flow path 7 .
[0137] The outlet 9 may be a hole through which the liquid passing through the main portion 50 and the auxiliary portion 70 can flow out.
[0138] For example, if Figure 1 In the embodiment shown, through holes are formed in a flow path sheet obtained by injecting rubber into a mold having a flow path pattern, and the sheet is bonded to a glass substrate, thereby forming a hole through which liquid can flow out after passing through the main part 50 and the auxiliary part 70 and can serve as the outlet 9.
[0139] The outlet 50out of the main portion 50 and the outlet of the auxiliary portion 70 are connected to the outlet 9 via the flow path 7 , and the liquid discharged from the main portion 50 and the auxiliary portion 70 is configured to reach the outlet 9 via the flow path 7 .
[0140] The flow path 7 may be configured to have the same function as the above-mentioned flow paths 5 and 6. The flow path 7 is configured by, for example, pillars.
[0141] As described above, the leukocyte capture device 1 of the present invention can be obtained by attaching a flow path sheet to a glass substrate, and the flow path sheet is obtained by injecting rubber into a mold formed with a flow path pattern. The size and material of the flow path sheet are not particularly limited. For example, it can be formed by resins such as silicone rubber, acrylic resin, polycarbonate, cyclic olefin polymer, cyclic olefin copolymer, polystyrene, polyethylene, polyethylene terephthalate, etc. In addition, the substrate attached with rubber is preferably glass, but it can also be other than glass.
[0142] Such a leukocyte capture device of the present invention separates only leukocytes from a blood-containing body into a buffer solution, and then captures the leukocytes. That is, when capturing leukocytes, the buffer solution containing the leukocytes does not contain red blood cells, proteins, etc. Therefore, it is possible to avoid these coagulated materials, etc. from being captured together with the leukocytes. Therefore, it is not necessary to remove unnecessary blood or clean the flow path.
[0143] [Example]
[0144] <Main part production>
[0145] First, silicone rubber (SILPOT184, Dow Corning) was injected into the mold on which the flow path pattern was formed.
[0146] Next, the silicone rubber was vulcanized at 120° C. for 30 minutes.
[0147] Next, the flow channel forming sheet was formed by peeling the silicone rubber from the silicone wafer.
[0148] Next, using a punch, holes to be the sample inlet 3 , the buffer inlet 4 , and the outlet 9 are formed.
[0149] <Joining>
[0150] The channel forming sheet and the glass substrate having the holes opened as described above were irradiated with vacuum ultraviolet light (L12530-01, Hamamatsu Optics) for 15 seconds. Then, the irradiated surfaces were bonded together to obtain Figure 1 The leukocyte capturing device 1 of the present invention is shown.
[0151] <Experiment>
[0152] Peripheral blood obtained from an adult male was diluted 10-fold with PBS to obtain a blood-containing body X1. PBS was used as a buffer Y1.
[0153] Next, the blood-containing body X1 is dripped into the sample inlet 3 , and the buffer solution Y1 is dripped into the buffer solution inlet 4 .
[0154] Next, the liquid is delivered from the outlet 9 by the negative pressure of the syringe pump.
[0155] The morphology of the transported liquid was confirmed by microscopy. Microscopic photographs (eyepiece 10x x objective lens 10x) are shown in Figure 8 .like Figure 8 As shown, it was confirmed that the blood-containing body X1 and the buffer solution Y1 flowed in a laminar flow. In addition, it was confirmed that the blood-containing body X2 did not flow into the main part 50. In addition, it was confirmed that the white blood cells were separated from the blood-containing body X1 and transferred to the buffer solution Y1.
[0156] Furthermore, it was not confirmed that the flow path in the main portion 50 was clogged after the liquid was continuously fed for 30 minutes.
[0157] In addition, it was confirmed that white blood cells were captured in the main portion 50 .
[0158] This application claims priority based on Japanese patent application No. 2022-51142 filed on March 28, 2022, and incorporates all the contents disclosed therein into this application.
[0159] Description of Reference Numerals
[0160] 1. Leukocyte Capture Device of the Present Invention
[0161] 3 Sample inlet
[0162] 4 Buffer outlet
[0163] 5, 6, 7 flow path
[0164] 9 Exit
[0165] 10 Leukocyte separation unit
[0166] 10in entrance of the leukocyte separation unit
[0167] 11. Plane
[0168] 11 S Surface of the flat part
[0169] 13 columns
[0170] 15 Cover
[0171] 20 White blood cells
[0172] 22 small particles
[0173] 50 Main Department
[0174] 50in main entrance
[0175] 50out main unit outlet
[0176] 52 Flat surface
[0177] 54 convex part
[0178] 56 Cover
[0179] 61 Capture Department
[0180] 63 Bypass
[0181] 70 Auxiliary Department
[0182] 80 partition wall
Claims
1. A leukocyte capture device for allowing a blood-containing body to pass through and for capturing leukocytes contained in the blood-containing body, wherein: have: A sample inlet for introducing the blood-containing body X1; Buffer inlet, for introduction of buffer Y1; The leukocyte separation unit is configured to have a planar portion and a plurality of columns extending in a direction perpendicular to the planar portion, wherein the blood-containing body X1 and the buffer solution Y1 flow in a specific same direction on the surface of the planar portion in a manner that they are adjacent to each other and between the column and another column adjacent thereto, When the surface of the planar portion is viewed from a direction parallel to a perpendicular line to the surface of the planar portion, the columns form a plurality of rows, each of which is arranged to form an angle θ with respect to the same direction Z in which the blood-containing fluid X1 and the buffer solution Y1 flow. In the direction perpendicular to the same direction Z when the surface of the planar portion is observed from a direction parallel to a perpendicular line to the surface of the planar portion, in the case of a structure using a deterministic lateral displacement method (DLD method) in which the interval between the pillar and another pillar adjacent thereto is set to g, Dc=1.4g×(1 / tanθ) -0.48 The defined boundary diameter Dc is smaller than the diameter of the white blood cell, In the process that the blood-containing body X1 and the buffer solution Y1 flow in the same specific direction Z, the white blood cells are separated from the blood-containing body X1, and the white blood cells are contained in the buffer solution Y1, thereby generating the buffer solution Y2 containing the white blood cells and the blood-containing body X2 which is the remaining part from which the white blood cells are separated, and discharging them; a main part, which allows the buffer solution Y2 discharged from the leukocyte separation unit to pass therethrough and captures the leukocytes contained in the buffer solution Y2; an auxiliary section through which the blood-containing body X2 discharged from the leukocyte separation unit passes and has the same flow path resistance as that of the main section; and an outlet for the liquid to flow out after passing through the main part and the auxiliary part, The main part is composed of: The main part has a planar portion and a plurality of convex portions arranged on the planar portion, and the buffer Y2 entering from the inlet passes on the surface of the planar portion in the main part and between the convex portion and another convex portion adjacent to the convex portion, and is discharged from the outlet. The convex portions are provided in layers on the surface of the planar portion, each layer includes a plurality of the convex portions, and the convex portions are configured so that the buffer Y2 that has passed through the layer on the inlet side passes through the layer on the outlet side adjacent to the layer on the inlet side. A capture portion having a width between the convex portion and another convex portion adjacent to the convex portion and a bypass portion having a width between 2 and 7.5 μm and 8 and 20 μm is formed in each layer. The width of the inlet side portion of the two convex portions constituting the capture portion is chamfered so as to gradually narrow toward the depth of the capture portion. The capturing portion is disposed as a part of another layer adjacent to the specific layer, facing the outlet side of the whole or a part of the bypass portion.
2. The leukocyte capture device according to claim 1, wherein: The auxiliary part has the same structure as the main part.
3. The leukocyte capture device according to claim 1 or 2, wherein: In the main portion, a specific layer and another layer adjacent to the specific layer have a width of 8 to 30 μm.
4. The leukocyte capturing device according to any one of claims 1 to 3, wherein In the main portion, a ratio of a width of the bypass portion to a width of the capturing portion is greater than 1 and less than or equal to 3.
5. The leukocyte capturing device according to any one of claims 1 to 4, wherein In the main portion, a portion other than the capturing portion at an end surface on the inlet side of the convex portion extends parallel to the slice direction, and an end surface of the convex portion constituting the bypass portion extends in a direction perpendicular to the slice direction.
6. The leukocyte capturing device according to any one of claims 1 to 5, wherein: The boundary diameter Dc is greater than or equal to 5 μm and less than 10 μm.
Citation Information
Cited By
Microparticle capturing device
CN116324367A
